CDC Recommends Bavarian Nordic Vaccine
- COPENHAGEN, Denmark – Bavarian Nordic, a biotechnology company based in Denmark, announced that the Advisory Commitee on Immunization Practices (ACIP) of the U.S.
- The recommendation applies to individuals 12 years of age and older who are traveling to regions experiencing a chikungunya outbreak.
- Paul Chaplin, president of Bavarian Nordic, stated, "Chikungunya is an increasing global public health concern, and this decision marks another step in our commitment to protect more individuals...
Bavarian Nordic‘s Chikungunya Vaccine Receives Key Recommendation
Table of Contents
- Bavarian Nordic’s Chikungunya Vaccine Receives Key Recommendation
- Chikungunya Vaccine: Your Questions Answered
- What is this news about a Chikungunya vaccine?
- What is Chikungunya?
- Who is the Chikungunya vaccine recommended for?
- What is VIMKUNYA?
- Where can I get the Chikungunya vaccine?
- What is ACIP?
- Why is this recommendation important?
- What are the next steps for the vaccine?
- What are the benefits of getting vaccinated against Chikungunya?
- Who is Bavarian Nordic?
COPENHAGEN, Denmark – Bavarian Nordic, a biotechnology company based in Denmark, announced that the Advisory Commitee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) has voted to recommend its chikungunya vaccine, VIMKUNYA, for the prevention of the disease.
Recommendation Details
The recommendation applies to individuals 12 years of age and older who are traveling to regions experiencing a chikungunya outbreak.
Company Statement
Paul Chaplin, president of Bavarian Nordic, stated, “Chikungunya is an increasing global public health concern, and this decision marks another step in our commitment to protect more individuals from this virus.”
Next Steps
The ACIP’s recommendation now awaits final approval from the director of the CDC and the U.S. Department of Health and Human Services.
About ACIP
ACIP, or Advisory Committee on Immunization Practices, provides guidance and recommendations regarding vaccine usage and schedules.
Chikungunya Vaccine: Your Questions Answered
What is this news about a Chikungunya vaccine?
Bavarian Nordic, a biotechnology company based in Denmark, announced that the Advisory Committee on Immunization Practices (ACIP) of the U.S.Centers for Disease Control and Prevention (CDC) has recommended its chikungunya vaccine, VIMKUNYA, for the prevention of the disease. This represents a significant step forward in protecting individuals from this virus.
What is Chikungunya?
Unfortunately, this article does not provide a definition of Chikungunya. Please refer to the CDC website for more facts.
Who is the Chikungunya vaccine recommended for?
The recommendation from ACIP specifically applies to individuals 12 years of age and older who are traveling to regions experiencing a chikungunya outbreak.
What is VIMKUNYA?
VIMKUNYA is the name of Bavarian Nordic’s chikungunya vaccine.
Where can I get the Chikungunya vaccine?
The article does not state when and where people can get the vaccine. Further information can be found by contacting the CDC.
What is ACIP?
ACIP stands for the Advisory Committee on immunization practices. This committee provides guidance and recommendations about vaccine usage and schedules.
Why is this recommendation important?
According to Paul Chaplin, president of Bavarian Nordic, “Chikungunya is an increasing global public health concern, and this decision marks another step in our commitment to protect more individuals from this virus.” This signifies the growing need for effective prevention of chikungunya.
What are the next steps for the vaccine?
The ACIP’s recommendation now awaits final approval from the director of the CDC and the U.S. Department of Health and Human Services.
What are the benefits of getting vaccinated against Chikungunya?
This article focuses on the recommendation and does not specify the benefits, but getting vaccinated can help prevent the disease. For more specifics, consult your healthcare provider.
Who is Bavarian Nordic?
Bavarian Nordic is a biotechnology company based in Copenhagen, Denmark.